Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by G1945Von Oct 27, 2023 8:45am
49 Views
Post# 35703696

RE:RE:Patent Info

RE:RE:Patent Info
Pandora wrote:
Pandora wrote:
Seems the patent application for the probe has been stymied by an examiner again. It got a Notice of Publication way back on June 24, 2021. It got it's first rejection on September 7, 2021. A lot of back and forth and arguments about the claims through 2021 and the first half of 2022 but ended with a final rejection on August 8, 2022. More discussion and debate in October 2022 and February 2023 culminating with another non-final rejection on February 28, 2023. It got resucitated in August 2023 with a request for an extension of time and new amendments to the claims for reconsideration. This appears to have ended once again with another final rejection as shown below. It seems no matter how hard they try the Inventor and the Examiner cannot come to terms on this. Whether it will be abandoned at this point or whether they will go another round is anybody's guess but it is at least grounded once again in the near term.

16/757,755 | 0822-053796:

DEVICE, SYSTEM AND/OR METHOD FOR POSITION TRACKING

Public view
Application #

16/757,755

Confirmation #

6458

Attorney Docket #

0822-053796

Patent #

-

Filing or 371 (c) date

04/20/2020

Status

Final Rejection Counted, Not Yet Mailed 10/22/2023




Details of the reaons for rejection of the probe patent have been posted today on the USPTO site.

In my humble opinion there definitely seems to be a lack of communication between the Inventor and the Examiner. The same reason's for rejection keep getting repeated. This is about the third time. I don't profess to be any kind of expert on patent application language but I do not understand why you can keep being told, what seems to be the same objections over and over again, and the changes don't happen. The Examiner(s) provide a phone number and suggest they are available to discuss all issues so if the two people are communicating on issues why do they not get resolved and changed to something acceptable by both? As I say, maybe I just don't understand.

To start off with there are 16 pages of other probe applications which have the same or similar components such as gyroscopes, accelerometers, sensors, magnetometers, and storage, so trying to justify why yours is a little different is a big hurdle.

Anyway they are given another 90 day window to address the issues and to resubmit. Around and round it goes, where and when it stops nobody knows. Is it important??

Maybe, just maybe, if the Inventor and the Examiner get together and address her issues line by line they will either end up at acceptance, or, not possible.

DEVICE, SYSTEM AND/OR METHOD FOR POSITION TRACKING



 
 
/ / /  
Maria Christina Talty - Examiner

Joseph M Santos Rodriguez - Primary Examiner


Pandora, thank you for keeping us updated on this very important outstanding issue. I trust you will be putting a question to Alvira at the Q&A portion of the AGM on November 1, 2023. We need to hear Alvira's take on this subject.

We need to know if the outcome is a complete rejection of the patent how will it affect the VMS+ in its operation moving forward?

What other options are there?

Will Ventripoint take advantage of the 90-day window, to hopefully resolve this matter to a successful conclusion and be done with it once and for all?

I trust Ventripoint hired a patent lawyer to deal with this issue.


G1945V


<< Previous
Bullboard Posts
Next >>